Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Renalytix AI PLC Sponsored ADR (RNLX : NSDQ)
 
 • Company Description   
Renalytix AI plc is an artificial intelligence-enabled in vitro diagnostics company. It focuses on optimizing clinical management of kidney disease. Renalytix AI plc is based in NEW YORK.

Number of Employees: 54

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.54 Daily Weekly Monthly
20 Day Moving Average: 118,635 shares
Shares Outstanding: 36.15 (millions)
Market Capitalization: $489.53 (millions)
Beta: 1.18
52 Week High: $35.71
52 Week Low: $12.99
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.54% -10.41%
12 Week -46.80% -44.34%
Year To Date -14.84% -7.97%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Finsgate 5-7 Cranwood Street
-
London,X0 EC1V 9EE
GBR
ph: 44-20-3139-2910
fax: -
investors@renalytixai.com http://www.renalytixai.com
 
 • General Corporate Information   
Officers
James McCullough - Chief Executive Officer and Director
Thomas McLain - President and Chief Commercial Officer
O. James Sterling - Chief Financial Officer
Fergus Fleming - Director
Ann Berman - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: IT Services
Sector: Computer and Technology
CUSIP: 75973T101
SIC: 8071
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 03/01/22
Share - Related Items
Shares Outstanding: 36.15
Most Recent Split Date: (:1)
Beta: 1.18
Market Capitalization: $489.53 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.16 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.63 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/01/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 8.15
Price/Cash Flow: -
Price / Sales: 248.11
EPS Growth
vs. Year Ago Period: -40.00%
vs. Previous Quarter: -75.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 2.12%
ROE
12/31/21 - -
09/30/21 - -45.44
06/30/21 - -38.11
ROA
12/31/21 - -
09/30/21 - -42.08
06/30/21 - -35.83
Current Ratio
12/31/21 - -
09/30/21 - 7.76
06/30/21 - 9.46
Quick Ratio
12/31/21 - -
09/30/21 - 7.76
06/30/21 - 9.46
Operating Margin
12/31/21 - -
09/30/21 - -1,717.89
06/30/21 - -
Net Margin
12/31/21 - -
09/30/21 - -1,717.89
06/30/21 - -
Pre-Tax Margin
12/31/21 - -
09/30/21 - -1,917.28
06/30/21 - -2,369.95
Book Value
12/31/21 - -
09/30/21 - 1.66
06/30/21 - 1.98
Inventory Turnover
12/31/21 - -
09/30/21 - -
06/30/21 - -
Debt-to-Equity
12/31/21 - -
09/30/21 - 0.00
06/30/21 - 0.00
Debt-to-Capital
12/31/21 - -
09/30/21 - 0.00
06/30/21 - 0.00
 

Powered by Zacks Investment Research ©